Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Overview of Exosomes01:36

Overview of Exosomes

2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RNF2 mediates H2A ubiquitination to promote colitis via suppressing monocyte-macrophage transition in mice.

Nature communications·2026
Same author

An interpretable memory forensics framework for unknown attack identification in power grid edge devices.

Scientific reports·2026
Same author

Oil-Water Flow Monitoring in Wellbores with Inflow Control Valves Using Distributed Acoustic Sensing.

Sensors (Basel, Switzerland)·2026
Same author

Ultrasound Domain Adaptation for Robust Kidney Segmentation via Spectral-Similarity-Guided Translation.

Journal of imaging informatics in medicine·2026
Same author

Non-canonical Platelet activation by oral squamous cell carcinoma extracellular vesicles through cooperative thrombin formation.

Biochemical and biophysical research communications·2026
Same author

Epidemiological characteristics of varicella in Xuzhou from 2015 to 2024: surveillance study.

BMC infectious diseases·2026
Same journal

Hijacking radiotherapy-induced chemokines with self-assembled molecular decoys for glioblastoma radio-immunotherapy.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

A one-step surface engineering strategy based on PEG-EGCG to improve systemic delivery and survival of transplanted mesenchymal stromal cells.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Selective silencing of placental anti-angiogenic factors in invasive trophoblasts via membrane-fusion divalent siRNA delivery for preeclampsia therapy.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Unified inactivation-mineralization: An engineered bacterial platform for synergistic radio-immunotherapy.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Loss of internal structural order induced by freezing and Lyophilization correlates with reduced in vitro activity of mRNA lipid nanoparticles.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Muscle contribution in lipid nanoparticle mediated mRNA vaccine delivery and efficacy.

Journal of controlled release : official journal of the Controlled Release Society·2026
See all related articles

Related Experiment Video

Updated: Jul 1, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

792

Smart exosomes enhance PDAC targeted therapy.

Justin F Creeden1, Jonathan Sevier1, Jian-Ting Zhang1

  • 1Department of Cell and Cancer Biology, University of Toledo, Toledo, OH, USA.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|March 2, 2024
PubMed
Summary
This summary is machine-generated.

Engineered exosomes ("Smart Exosomes") enhance pancreatic cancer therapy by improving tumor targeting and reducing clearance. This novel approach boosts drug delivery and efficacy for cancer treatment.

Keywords:
BioengineeringCD47CD9Drug deliveryExosomesGemcitabinePaclitaxelPancreatic cancerRGD

More Related Videos

Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

25.1K
Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

11.2K

Related Experiment Videos

Last Updated: Jul 1, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

792
Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

25.1K
Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

11.2K

Area of Science:

  • Biotechnology
  • Nanomedicine
  • Cancer Therapy

Background:

  • Exosomes are natural nanocarriers for drug delivery but face challenges in tumor targeting and rapid clearance by the mononuclear phagocyte system (MPS).
  • Existing exosome therapies are limited by poor targeting of cancer cells and short circulation times, hindering clinical application.

Purpose of the Study:

  • To engineer exosomes for enhanced targeting of pancreatic ductal adenocarcinoma (PDAC) cells and reduced MPS clearance.
  • To evaluate the therapeutic efficacy of engineered exosomes in preclinical models of pancreatic cancer.

Main Methods:

  • Engineered exosomes (ExoSmart) co-displaying RGD and CD47p110-130 via CD9 modification.
  • Assessed ExoSmart binding to αvβ3 on PDAC cells and cellular uptake in vitro and in vivo.
  • Evaluated ExoSmart's interaction with macrophages (SIRPα) to inhibit phagocytosis and reduce MPS clearance.

Main Results:

  • ExoSmart exhibited enhanced binding to PDAC cells and increased cellular uptake.
  • Engineered exosomes demonstrated reduced clearance by the liver and spleen due to inhibited macrophage phagocytosis.
  • Increased chemotherapeutic efficacy was observed in PDAC models treated with ExoSmart.

Conclusions:

  • Engineered exosomes (ExoSmart) represent a promising strategy for enhancing pancreatic cancer therapy.
  • This approach improves PDAC targeting and prolongs circulation time, offering significant translational potential for cancer treatment.
  • Novel peptide-engineered exosome strategies provide a foundation for future advancements in exosome-based drug delivery.